Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why D-Wave Quantum Stock Is Soaring Today (Fool) +++ D-WAVE Aktie +4,53%

ACTINOGEN Aktie

 >ACTINOGEN Aktienkurs 
0.015 EUR    +7.1%    (Tradegate)
Ask: 0.0155 EUR / 104896 Stück
Bid: 0.015 EUR / 113637 Stück
Tagesumsatz: 201000 Stück
Realtime Kurs von 8 bis 22 Uhr!
ACTINOGEN Aktie über LYNX handeln
>ACTINOGEN Performance
1 Woche: +11,1%
1 Monat: +42,9%
3 Monate: -3,2%
6 Monate: -3,2%
1 Jahr: -69,7%
laufendes Jahr: -9,1%
>ACTINOGEN Aktie
Name:  ACTINOGEN MEDICAL LTD.
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000ACW3 / A0MZH8
Symbol/ Ticker:  3AC (Frankfurt)
Kürzel:  FRA:3AC, ETR:3AC, 3AC:GR
Index:  -
Webseite:  https://actinogen.com.au/
Marktkapitalisierung:  46.14 Mio. EUR
Umsatz:  -
EBITDA:  -9.8 Mio. EUR
Gewinn je Aktie:  -
Schulden:  0.15 Mio. EUR
Liquide Mittel:  12.07 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / 37.08%
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / 3.5 / -
Gewinnm./ Eigenkapitalr.:  - / -53.73%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  ACTINOGEN
Letzte Datenerhebung:  23.07.25
>ACTINOGEN Eigentümer
Aktien: 3177.15 Mio. St.
f.h. Aktien: 2560 Mio. St.
Insider Eigner: 16.24%
Instit. Eigner: 0.68%
Leerverk. Aktien: -
>ACTINOGEN Peer Group

 
30.06.25 - 14:30
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer′s disease trial and interim analysis timeline (PR Newswire)
 
Interim analysis planned for January 2026 with final trial results in late 2026 Highlights: With the 100th participant enrolled in the XanaMIA trial, the timeline for the planned interim analysis is confirmed for January 2026 and the timeline for final results reconfirmed for late 2026 An......
30.06.25 - 02:01
With 100 enrolled and $13.8M in hand, Actinogen’s Xanamem timeline is in full swing (Market Herald)
 
Actinogen Medical (ASX:ACW) has this week enrolled its 100th participant for its…...
26.03.25 - 23:24
Actinogen targets $20B Alzheimer′s market with Xanamem (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
24.02.25 - 07:01
Actinogen reports busy 6 months as development of Xanamem molecule ramps up (Market Herald)
 
Actinogen Medical Ltd (ASX:ACW) said its net loss after tax for the…...
17.01.25 - 08:30
IN BRIEF: Cambridge Cognition extends partnership for Alzheimer′s test (Alliance)
 
Cambridge Cognition Holdings PLC - Cambridge, England-based brain health software - Expands partnership with Actinogen Medical Ltd for phase 2b/3 XanaMIA Alzheimer's trial. Says Actinogen......
12.11.24 - 03:43
Actinogen receives $9M R&D tax rebate to fund Alzheimer’s trial (Market Herald)
 
Actinogen Medical Ltd (ASX:ACW) has received a $9 million R&D (research and…...
24.09.24 - 04:25
Actinogen Medical ramps up Alzheimer′s treatment trials, targeting fast-track global approvals (Market Herald)
 
Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and…...
18.09.24 - 08:14
XFRA : 3AC: Wiederaufnahme/Resumption (XETRA)
 
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 AB/FROM ONWARDS 18.09.2024...
18.09.24 - 04:13
Australia′s Actinogen Medical falls on discounted placement (Reuters EN)
 
Australia's Actinogen Medical falls on discounted placement...
18.09.24 - 04:06
Why Actinogen Medical, Flight Centre, JB Hi-Fi, and NextDC shares are falling today (Fool)
 
Let's see why these shares are out of form on hump day. The post Why Actinogen Medical, Flight Centre, JB Hi-Fi, and NextDC shares are falling today appeared first on The Motley Fool Australia....
16.09.24 - 08:14
XFRA : 3AC: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 BAW/UFN...
16.09.24 - 07:49
XFRA : INSTRUMENT_SUSPENSION - AU000000ACW3 (XETRA)
 
Instrument ID [240] (3AC - AU000000ACW3) suspended...
26.08.24 - 04:49
Actinogen Medical′s Xanamem shows promising results in depression treatment trials (Small Caps)
 
Australian biotechnology company Actinogen Medical (ASX: ACW) has received further positive analysis from studies of its Xanamem treatment for symptoms of depression. The consistent benefits observed in the XanaCIDD phase 2a depression trial data support the conclusion that a 10 milligram Xanamem dose is clinically active in controlling brain cortisol and has clinically-significant anti-depressant activity. […] The post Actinogen Medical's Xanamem shows promising results in depression treatment trials appeared first on Small Caps....
26.08.24 - 02:37
Actinogen says novel antidepressant Xanamem shows significant improvements on four week 10mg daily dose (Market Herald)
 
Actinogen (ASX:ACW) has reported success in using its novel antidepressant Xanamem to…...
14.08.24 - 05:48
Why Actinogen, ASX, Burgundy Diamond, and Lifestyle Communities shares are sinking today (Fool)
 
These shares are having a tough time on hump day. But why The post Why Actinogen, ASX, Burgundy Diamond, and Lifestyle Communities shares are sinking today appeared first on The Motley Fool Australia....
13.08.24 - 02:37
Actinogen Medical weighs in on its latest results to market (Market Herald)
 
Actinogen Medical (ASX:ACW) recently announced results from its XanaCIDD Phase 2a trials,…...
12.08.24 - 08:14
XFRA : 3AC: Wiederaufnahme/Resumption (XETRA)
 
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 AB/FROM ONWARDS 12.08.2024...
12.08.24 - 04:06
Why Actinogen, Aurizon, Beach Energy, and PYC shares are sinking today (Fool)
 
These shares are starting the week in the red. But why? The post Why Actinogen, Aurizon, Beach Energy, and PYC shares are sinking today appeared first on The Motley Fool Australia....
08.08.24 - 08:08
XFRA : 3AC: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL ACTINOGEN MEDICAL LTD. 3AC AU000000ACW3 BAW/UFN...
08.08.24 - 07:52
XFRA : INSTRUMENT_SUSPENSION - AU000000ACW3 (XETRA)
 
Instrument ID [240] (3AC - AU000000ACW3) suspended...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Unzufriedenheit ist die erste Stufe zum Fortschritt für den einzelnen wie für die Nation. - Oscar Wilde
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!